Clarityn Allergy Liquid 60 mL is a trusted, over-the-counter (OTC) non-drowsy antihistamine oral liquid containing loratadine as the active ingredient. Formulated as a pleasant-tasting oral syrup, Clarityn Allergy Liquid is designed to provide fast, effective, and sustained 24-hour relief from a wide range of allergic conditions in children aged 2 years and above and in adults who prefer or require a liquid formulation over tablets.
Each 5 mL of syrup contains loratadine 5 mg, allowing accurate and flexible weight- and age-based dosing across the paediatric age range. Clarityn Allergy Liquid shares the same clinically proven active ingredient as Clarityne 10 mg Tablets but in a child-friendly liquid format that eliminates the challenge of tablet swallowing in younger patients. If you are looking to buy Clarityn Allergy Liquid in Kenya, this product is widely available at registered pharmacies nationwide and is one of the most recommended non-drowsy allergy syrups for allergy treatment in Kenya in children and adults alike. The price of Clarityn Loratadine Syrup in Kenya is accessible, making it a practical and affordable first-line choice for managing allergic conditions in the paediatric and adult populations.
Key Benefits
- Clinically proven non-drowsy antihistamine liquid — loratadine is one of the most consistently non-sedating antihistamines available, safe for use during school, work, and daily activities
- Once-daily dosing delivers full 24-hour allergy symptom control
- Child-friendly liquid format — ideal for children aged 2 years and above who cannot or will not swallow tablets
- Fast onset of action — symptom relief typically begins within 1–3 hours of the first dose
- Effective for both seasonal and perennial allergic conditions
- Relieves sneezing, runny nose, itchy and watery eyes, nasal congestion, and allergic skin itching
- Suitable for children from 2 years of age and adults
- Accurate dosing facilitated by the liquid format — precise weight-based and age-based dosing in paediatric patients
- 60 mL bottle provides a generous supply for sustained allergy management
- Well-established global safety and efficacy profile with decades of widespread clinical use
- OTC — no prescription required for standard use in children aged 2 years and above and adults
What It Is & How It Works
Active Ingredient
Each 5 mL of syrup contains:
| Active Ingredient | Strength per 5 mL | Role |
|---|---|---|
| Loratadine | 5 mg | Second-generation selective peripheral H1 antihistamine — blocks histamine receptors to relieve allergy symptoms without significant CNS sedation |
How It Works
When the immune system is exposed to an allergen — such as pollen, dust mites, cockroach allergens, pet dander, mould spores, or insect stings — sensitised mast cells and basophils release histamine into surrounding tissue. Histamine binds to H1 receptors distributed throughout the body — in the nasal mucosa, conjunctiva, skin, and upper airway — triggering the characteristic cascade of allergy symptoms including sneezing, runny nose, nasal congestion, itchy and watery eyes, and skin rashes.
Loratadine is a potent, long-acting, selective peripheral H1 receptor antagonist that works by competitively occupying H1 receptors before histamine can bind to them. By blocking histamine attachment at these receptor sites, loratadine effectively prevents and relieves the full cascade of histamine-driven allergy symptoms.
Why Loratadine Is Non-Sedating
- P-glycoprotein efflux at the blood-brain barrier — loratadine is efficiently excluded from the central nervous system by the P-glycoprotein efflux transporter, preventing significant central H1 receptor occupancy and thereby avoiding the sedation associated with older antihistamines
- High peripheral H1 receptor selectivity — loratadine has minimal affinity for muscarinic, dopaminergic, alpha-adrenergic, or serotonergic receptors, greatly reducing anticholinergic and sedative side effects
- Active metabolite desloratadine — loratadine is converted in the liver to desloratadine, its pharmacologically active metabolite, which shares the same peripheral selectivity and non-sedating profile and contributes to the prolonged 24-hour duration of action
- No clinically significant impairment of psychomotor function — at recommended doses, loratadine does not impair driving ability, school performance, or occupational function — a critical advantage in paediatric and working adult populations
Classification
This product is classified as an Over-the-Counter (OTC) medicine in Kenya. It can be purchased without a prescription for standard use in children aged 2 years and above and adults. Consult a pharmacist or doctor if you are unsure whether this product is suitable for your child or for any specific medical condition.
Formulation
Oral syrup. Each bottle contains 60 mL. Each 5 mL of syrup contains loratadine 5 mg. A calibrated oral syringe or dosing spoon should be used to measure doses accurately — do not use a household teaspoon. The syrup has a pleasant flavour to support compliance in children.
Uses & Indications
Clarityn Allergy Liquid may be used for the symptomatic relief of:
- Seasonal allergic rhinitis (hay fever) — sneezing, runny nose, nasal congestion, and itchy, watery eyes triggered by pollen, grass, and trees
- Perennial allergic rhinitis — year-round allergy symptoms triggered by dust mites, pet dander, cockroach allergens, and mould spores
- Allergic conjunctivitis — itchy, red, and watery eyes caused by airborne allergens
- Chronic idiopathic urticaria (hives) — itchy, raised skin welts without an identified cause
- Acute allergic urticaria — skin hives and rashes triggered by allergens, food reactions, or insect bites
- Allergic skin itching and rash — including contact allergic reactions and dermographism
- Insect bite and sting reactions — relief of localised itching, redness, and mild swelling associated with mild allergic responses
IMPORTANT: Clarityn Allergy Liquid is indicated for the relief of mild to moderate allergy symptoms. It is NOT intended for the treatment of severe allergic reactions (anaphylaxis), acute severe asthma, or angioedema involving the throat or airway — these are life-threatening medical emergencies requiring immediate medical attention, adrenaline (epinephrine) administration, and emergency services. Seek emergency care without delay in these situations.
Dosage & Administration
NOTE: Use only as directed on the label or by a pharmacist. Do not exceed the recommended dose or duration of use.
| Age Group | Dose | Frequency | Maximum Daily Dose |
|---|---|---|---|
| Adults and children 12+ years | As directed | As directed | As directed |
| Children 6–11 years (body weight above 30 kg) | As directed | As directed | As directed |
| Children 6–11 years (body weight 30 kg or below) | As directed | As directed | As directed |
| Children 2–5 years | As directed | As directed | As directed |
| Children under 2 years | As directed | — | — |
| Patients with severe liver impairment | As directed | As directed | As directed |
| Patients with severe renal impairment | As directed | As directed | As directed |
Administration Instructions
- Shake the bottle gently before each use if directed on the label
- Measure each dose carefully using the calibrated oral syringe or dosing spoon provided — do not use a household teaspoon as this may result in inaccurate dosing
- May be taken with or without food — food does not significantly affect the absorption of loratadine
- Take at the same time each day to maintain consistent 24-hour allergy coverage
- For children with seasonal allergies, begin use at the onset of the allergy season or just before for best preventive effect
- Do not give more than the stated maximum daily dose for the child’s age and weight group
- Keep the bottle tightly closed after each use
- If a dose is missed, give it as soon as remembered — if it is almost time for the next dose, skip the missed dose and continue as normal; do not double dose
- For chronic conditions such as perennial allergic rhinitis or chronic urticaria, consult a healthcare provider regarding long-term use beyond 6 weeks
Possible Side Effects
Like all medicines, Clarityn Allergy Liquid may cause side effects in some people. These are generally very mild and uncommon at recommended doses. Stop use and consult your pharmacist or doctor if you or your child experiences any of the following:
Common
- Headache — mild and usually transient
- Dry mouth — mild; significantly less than with first-generation antihistamines
- Fatigue — very mild; loratadine is clinically categorised as non-sedating but individual responses may occasionally vary
- Nausea or stomach discomfort — usually mild
Less Common
- Drowsiness — rare at recommended doses; however individual sensitivity varies
- Nervousness or excitability — an uncommon but recognised paradoxical reaction in young children taking antihistamines; report to a pharmacist or doctor if observed
- Palpitations or tachycardia — uncommon; reported rarely
- Elevated liver enzymes — very rare; monitor in patients with pre-existing hepatic impairment
WARNING: Rare but serious — seek immediate medical attention if you or your child experiences: severe allergic reactions to loratadine itself (rash, swelling of the face, lips, tongue, or throat, difficulty breathing, or anaphylaxis), severe skin reactions, or signs of liver dysfunction (yellowing of the skin or eyes, dark urine, or persistent abdominal pain). These are rare but require prompt medical evaluation.
This is not a complete list of side effects. Consult a pharmacist or doctor for full information.
Warnings & Precautions
CONTRAINDICATION: Do NOT use Clarityn Allergy Liquid if the patient is known to be allergic to loratadine, desloratadine, or any excipient in this formulation.
Do Not Use If:
- The child is under 2 years of age without specific medical advice
- The patient has a known hypersensitivity to loratadine, desloratadine, or any piperidine antihistamine
- The patient has been specifically advised to avoid antihistamines by a healthcare provider
Use With Caution If the Patient Has:
- Severe liver disease or hepatic impairment — loratadine is extensively metabolised by the liver via CYP3A4 and CYP2D6 enzymes; every-other-day dosing is required in severe hepatic impairment to prevent drug accumulation; consult a doctor before use
- Severe renal impairment — every-other-day dosing is similarly recommended; consult a doctor before use
- Phenylketonuria (PKU) — check the syrup excipient list on the label for aspartame or phenylalanine content
- Rare hereditary conditions including galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption — check excipient content with your pharmacist as some liquid formulations contain sugars
Do Not Combine With (Selected Key Interactions):
- Medicines that inhibit CYP3A4 or CYP2D6 enzymes — including ketoconazole, itraconazole, erythromycin, clarithromycin, and cimetidine — these may increase loratadine plasma levels and the risk of side effects; consult a pharmacist
- Alcohol — although loratadine is non-sedating, concurrent alcohol consumption may enhance any residual CNS effects
- Other antihistamines — combined use increases the risk of antihistamine side effects without additional therapeutic benefit
CLINICAL NOTE (Kenya-specific): Clarityn Allergy Liquid is particularly well suited to the Kenyan paediatric population, where allergic rhinitis, urticaria, and insect bite reactions are among the most common reasons for pharmacy consultations in children. Dust mite allergens, cockroach allergens, outdoor moulds, and grass pollens are significant perennial and seasonal triggers for allergic rhinitis across Kenya — particularly in densely populated urban areas such as Nairobi, Mombasa, and Kisumu, where housing conditions and environmental allergen loads are high. The non-sedating profile of loratadine is especially valuable in school-age children, where sedating antihistamines can impair learning, concentration, and academic performance. Parents and caregivers should be advised that paradoxical excitability — an unusual increase in activity or restlessness — can occasionally occur in young children taking antihistamines and should be reported to a pharmacist or doctor promptly if observed. Children with persistent or worsening allergy symptoms despite antihistamine use should be referred for medical evaluation to rule out asthma, which frequently co-exists with allergic rhinitis in Kenyan children.
Keep out of reach of children. In case of accidental overdose, contact a poison control centre or emergency services immediately.
Storage Instructions
- Store below 25°C in a cool, dry place
- Protect from direct sunlight and excessive heat
- Keep away from moisture and humidity
- Keep the bottle tightly closed after each use
- Do not refrigerate unless specifically directed on the label
- Store out of reach and sight of children
- Do not use after the expiry date printed on the bottle or carton
- Do not transfer the syrup to another container
- Dispose of unused or expired syrup safely at your local registered pharmacy
Mandatory Disclaimer
Always read the label and use as directed. Do not exceed the stated dose for the patient’s age and weight group. If allergy symptoms persist beyond 6 weeks, worsen significantly, or are accompanied by fever, difficulty breathing, facial swelling, or signs of a severe allergic reaction, stop use and seek immediate medical attention. Frequent or severe allergic reactions may indicate an underlying condition requiring formal allergy assessment and specialist management. This product information is provided for general guidance only and does not replace professional medical or pharmaceutical advice.
Reviews
There are no reviews yet.